Novel therapeutic option for orbital atypical lymphoid hyperplasia

Simple item page
dc.contributor.authorTalaulikar, Diptien_AU
dc.contributor.authorTridgell, Daviden_AU
dc.contributor.authorLeong, David C Sen_AU
dc.contributor.authorCherian, Mayaen_AU
dc.contributor.authorSunderland, Kenen_AU
dc.contributor.authorDahlstrom, Janeen_AU
dc.date.accessioned2015-12-10T23:15:59Z
dc.date.issued2010
dc.date.updated2016-02-24T08:08:10Z
dc.description.abstractOcular lymphoid tumours represent a spectrum of lymphoproliferative disease and can be subdivided into benign or reactive lymphoid hyperplasia, indeterminate or atypical lymphoid proliferations and malignant lymphoma. Treatment options include a wait and
dc.identifier.issn1442-6404
dc.identifier.urihttp://hdl.handle.net/1885/64872
dc.publisherBlackwell Science Asia
dc.sourceClinical and Experimental Ophthalmology
dc.subjectKeywords: rituximab; adult; article; B lymphocyte; case report; clinical decision making; exophthalmos; female; flow cytometry; follow up; human; immunoglobulin heavy chain gene; immunophenotyping; lymphoid hyperplasia; nuclear magnetic resonance imaging; orbit dis B-lymphocyte; Haematopathology; Lymphoproliferative disorder; Orbital; Pathology of lymphoid lesion
dc.titleNovel therapeutic option for orbital atypical lymphoid hyperplasia
dc.typeJournal article
local.bibliographicCitation.issue9
local.bibliographicCitation.lastpage894
local.bibliographicCitation.startpage892
local.contributor.affiliationTalaulikar, Dipti, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationTridgell, David, Canberra Hospital
local.contributor.affiliationLeong, David C S, Canberra Hospital
local.contributor.affiliationDahlstrom, Jane, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationCherian, Maya, Canberra Hospital
local.contributor.affiliationSunderland, Ken, The Canberra Hospital
local.contributor.authoremailu4283279@anu.edu.au
local.contributor.authoruidTalaulikar, Dipti, u4283279
local.contributor.authoruidDahlstrom, Jane, u1856057
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor111301 - Ophthalmology
local.identifier.ariespublicationf2965xPUB1012
local.identifier.citationvolume38
local.identifier.doi10.1111/j.1442-9071.2010.02378.x
local.identifier.scopusID2-s2.0-78650080799
local.identifier.thomsonID000285109700012
local.identifier.uidSubmittedByf2965
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
01_Talaulikar_Novel_therapeutic_option_for_2010.pdf
Size:
847.18 KB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2024 LYRASIS